1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Relationship between hydrocephalus etiology and clinical outcome
Clinical Outcome Hydrocephalus PAS(n = 11; 28.9%) SAS(n = 18; 47.4%) AC(n = 6; 15.8%) CH(n = 3; 7.9%) No improvement(n = 6; 15.8%) 1 (2.6%) 4 (10.5%) 1 (2.6%) Partial Improvement(n = 17; 44.7%) 3 (7.9%) 12 (31.6%) 1 (2.6%) 1 (2.6%) Good outcome(n = 13; 34.2%) 7 (18.4%) 5 (13.2%) 1 (2.6%) Clinical worsening(n = 2; 5.3%) 1 (2.6%) 1 (2.6%)
Note.—PAS indicates primary aqueduct stenosis; SAS, secondary aqueduct stenosis; AC, Arnold Chiari malformation; CH, communicating hydrocephalus.